PATENT CLAIM ANALYSIS

Application Number: 16045993
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "230500"]

Abstract:
The present disclosure provides a compound of formula (I): or a pharmaceutically acceptable salt thereof, and its therapeutic uses for activating a growth factor pathway, promoting wound healing, promoting tissue repair, and treating hearing loss, skeletal muscle loss, organ degeneration, tissue damage, neurodegeneration, and muscular atrophy. The disclosure further provides pharmaceutical compositions and combinations. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

Claim (Index 15):
The compound according to  claim 1  or a pharmaceutically acceptable salt thereof, wherein R 2  is H.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.45763
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12994250', '13114829', '14972482', '13084181', '14774839']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.750375279863218
- 35 USC 102 Novelty (BERT): 0.519446876450452
- Combined Prediction Score: 0.7272824395219414
- Mean Citation Score: 285.825828
- Max Citation Score: 296.1184
- Similarity Product: 227.2835044809341

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test